Our body's own defense system not only clears away bacteria and viruses, it can also fight cancer. However, not all tumor ...

Now, technological advances like rapid DNA sequencing, lymph node targeting, and AI-informed antigen ... cancer shows that Elicio’s vaccine induced 100-fold increases in tumor-specific T cells ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

A new study reveals blood tests can predict melanoma recurrence by detecting circulating tumor DNA. Research shows 80% of stage 3 melanoma patients with positive tests experience a return of cancer.

The new test looks for a specific type ... up about half of all skin cancer sufferers -- determined that approximately 80% of those who had evidence of circulating tumor DNA, or ctDNA, in their ...

A newly developed radiolabeled antibody that targets the cancer antigen IL13Rα2 has been ... rendering it an ideal target for noninvasive and specific tumor detection. "So far, no IL13Rα2 ...

Scientists have discovered a new immunotherapy strategy that reduces cancer recurrence in mouse experimental models. The study, published in Nature Communications, shows that a specific subtype of ...

A multi-institutional team developed a chimeric antigen receptor ... drugs are designed to target tumor-specific antigens, which are molecules only expressed by cancer cells.